Metrics to compare | CEL | Peers Peers - average of corresponding metrics from companies closely matching CEL: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCELPeersSector |
|---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.0x | 2.6x | |
Price / LTM Sales | 0.0x | 0.0x | 3.2x | |
Upside (Analyst Target) | 0.0% | 0.0% | 50.8% | |
Fair Value Upside | Unlock | 0.0% | 7.7% | Unlock |
CELADON PHARMACEUTICALS LIMITED engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders. CELADON PHARMACEUTICALS LIMITED was formerly known as Celadon Pharmaceuticals Plc and changed its name to CELADON PHARMACEUTICALS LIMITED in August 2025. The company was founded in 2018 and is based in London, the United Kingdom.